Thyrocare Q2 revenue rises 25.1% as EBITDA stays flat
In short
Thyrocare reported Q2 revenue of ₹271 crore, up 25.1% from ₹217 crore.
EBITDA rose 25.1% to ₹89 crore from ₹71 crore, and the margin stayed at 33%. The source snippet does not give the profit-fall number from the headline.
What the reporting says
Thyrocare reported Q2 revenue of ₹271 crore, up 25.1% from ₹217 crore, while EBITDA rose 25.1% to ₹89 crore from ₹71 crore. The EBITDA margin stayed flat at 33% year on year, according to the CNBC TV18 summary. The original headline says profit fell 68% because of a ₹45 crore impairment charge, but the provided source snippet does not include that figure, so the direct readout is limited to revenue and EBITDA growth.
Why it matters
Thyrocare’s Q2 update showed revenue climbing to ₹271 crore from ₹217 crore and EBITDA rising to ₹89 crore from ₹71 crore, with the margin steady at 33%. The headline says profit fell 68% due to a ₹45 crore impairment charge, but that detail is not present in the provided summary. The result suggests stronger operating performance, though the bottom-line pressure remains partly unverified in the snippet.